期刊文献+

应用Fura-2/AM荧光双波长法研究抑肽酶对血小板活化的保护作用 被引量:3

Protective mechanism of aprotinin in platelet activation by Fura-2/AM dual-wavelength method
下载PDF
导出
摘要 目的 探讨抑肽酶对血小板活化的保护机制。方法 用钙荧光指示剂Fura 2 AM负载人洗涤血小板 ,用荧光双波长分光光度计比值法测定静息血小板胞浆游离钙浓度 ( [Ca2 + ] i)及凝血酶、抑肽酶对 [Ca2 + ] i 的影响。结果 在生理胞外Ca2 + 浓度时 ,正常人血小板 [Ca2 + ] i 静息水平为 ( 15 1 840± 2 8 719)nmol L ,凝血酶可引起血小板 [Ca2 + ] i 的明显增加(P <0 0 1) ,抑肽酶呈剂量依赖性地抑制由凝血酶引起的 [Ca2 + ] i 的增加 (P <0 0 1)。结论 抑肽酶的保护血小板机制与其抑制血小板内 [Ca2 + ] i Objective To study the possible mechanisms of aprotinin in the protection of platelets. Methods Cytosolic free calcium concentration ([Ca 2+ ]i) was determined in calcium fluorescent indicator Fura 2/AM loaded washed human platelets by using dual wavelength spectrofluorophotometer. The mean value of resting [Ca 2+ ]i and the changes of [Ca 2+ ]i response to thrombin and aprotinin were observed. Results In the presence of extracellular Ca 2+ at the dose of 1 mmol/L, the resting level of [Ca 2+ ]i in platelets of human was (151.840±28.719) nmol/L. Thrombin stimulated the rise in [Ca 2+ ]i in the presence of Ca 2+ at the dose of 1 mmol/L, and the effects were inhibited by aprotinin in a concentration dependent manner ( P <0.01). Conclusion Aprotinin is an anti platelet agent and may exert its action through inhibiting the [Ca 2+ ]i mobilization in platelets.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2004年第17期1576-1579,共4页 Journal of Third Military Medical University
关键词 抑肽酶 血小板 钙指示剂 胞浆游离钙 aprotinin platelet calcium indicator cytosolic free calcium
  • 相关文献

参考文献11

  • 1Santamaria A, Mateo J, Oliver A, et al. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss[J]. Haematologica, 2000, 85(12):1277 - 1284.
  • 2Porte R J, Molenaar I Q, Begliomini B, et al. Aprotinin and transfusion requirement in orthotopic liver transplantation: a multicentre randomized double-blind study. EMSALT Study Group [ J ]. Lancet, 2000, 355(9212): 1303 - 1309.
  • 3Coles B, Bloodsworth A, Eiserich J P, et al. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP[J].J Biol Chem, 2002, 277(8): 5832
  • 4Volf I, Roth A, Moeslinger T, et al. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding[J]. Thromb Res, 2000, 97(6):441 - 449.
  • 5Grynkiewicz G, Poenie M, Tsien R Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties[J]. J Biol Chem, 1985, 260(6): 3440 - 3450.
  • 6McDonough P M, Button D C. Measurement of cytoplasmic calcium concentration in cell suspensions: correction for extracellular Fura-2 through use of Mn2+ and probenecid[J]. Cell Calcium, 1989, 10(3): 171- 180.
  • 7Galeazzi L, Casoli T, Giunta S, et al. Beta-Amyloid fragment 25-35 induces changes in cytosolic free calcium in human platelets [ J ]. Ann N Y Acad Sci, 2000, 903:451-456.
  • 8Di-Virgilio F, Fasolato C, Steinberg T H. Inhibitors of membrane transport system for organic anions block Fura-2 excretion from PC12 and N2A cells [J]. Biochem J, 1988, 256(3): 959- 963.
  • 9Berts A, Minneman KP. Tyrosine kinase inhibitors and Ca2+ signaling: direct interactions with fura-2[J]. Eur J Pharmacol, 2000, 389(1): 35-40.
  • 10Rink T J, Smith S W, Tsien R Y. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion[J]. FEBS Lett, 1982, 148(1): 21-26.

二级参考文献2

共引文献1

同被引文献26

  • 1Aoki H, Mizobe T, Nozuchi S, et al. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation.Anesthesiology, 1998,88 : 362-370.
  • 2Dogan IV, Ovali E, Eti Z, et al. The in vitro effects of isoflurane,sevoflurane, and propofol on platelet aggregation. Anesth Analg, 1999,88:432-436.
  • 3Kohro S, Yamakage M, Omote T, et al. In vitro effects of propofol on blood coagulability and fibrinolysis by the use of thromboelastograph technique. Acta Anaesthesiol Scand, 1999,43 : 217-219.
  • 4Law NL, Ng KF, Irwin MG, et al. Comparison of coagulation and blood loss during anaesthesia with inhaled isoflurane or intravenous propofol. Br J Anaesth,2001,86:94-98.
  • 5Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 1962,194:927-929.
  • 6Kohro S, Yamakage M. Direct inhibitory mechanisms of halothane on human platelet aggregation. Anesthesiology, 1996, 85 : 96-106.
  • 7Escudero C, Santos M, Bujan J, et al. Optical aggregometry versus the PFA-100: experimental studies in pigs treated with propofol. Platelets,2001,12:133-137.
  • 8Hirakata H, Nakamura K, Yokubol B, et al. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro.Anesthesiology, 1999,91 : 1361-1369.
  • 9Andrews RK, Lopez JA, Bemdt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biul, 1997,29:91-105.
  • 10Zhou L, Xu N, Nilsson A. Intralipid rapidly attenuates the agonist-induced activation of rat platelets in vitro. Thromb Res, 1997,85:53-62.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部